抗MDA-5与病毒性肺炎复杂的快速进展的间歇性肺病相关 - 一种致命的结果
Saikat Mitra1, Nithye Parvathy2, Mandeep Garg3
1Postgraduate Institute of Medical Education and Research, Department of Histopathology, Chandigarh, India.
Autopsy & case reports
|October 7, 2024
概括
这一案例突显了由H1N1流感复杂的抗MDA5皮肤肌炎,导致致命的呼吸衰竭. 反MDA5抗体是这种严重的自身免疫性疾病的关键生物标志物.
科学领域:
- 类风湿病学 类风湿病学
- 肺部病理学 肺部病理学
- 病理学 病理学 病理学
背景情况:
- 皮肤肌肉炎是一种全身性自身免疫性疾病,表现各异.
- 抗MDA5抗体阳性定义了一组皮肤肌炎患者的亚组,这些患者患有骨髓病,皮肤和快速间歇性肺病.
- 反Ro-52抗体与自身免疫性疾病有关,包括肌肉炎和间歇性肺病.
研究的目的:
- 报告与抗MDA5和抗Ro-52相关的皮肤肌炎的致命病例.
- 为了说明这种疾病的严重肺部并发症,由H1N1流感加剧.
- 强调抗MDA5抗体在皮肤肌炎的诊断和预后意义.
主要方法:
- 一个22岁的男性有六个月的系统性症状史的病例报告.
- 临床评估,包括对呼吸困难的成像.
- 尸体解剖检查与肺部和肌肉组织的组织病理学分析.
- 死后血清学检测自身免疫抗体.
主要成果:
- 该患者出现了与急性呼吸困难综合征相一致的症状,并对H1N1流感呈阳性.
- 尸体解剖揭示了扩散的膜损伤和肺部非特异性间歇性肺炎,与微妙的肌病变化.
- 死后血清学证实了Anti-MDA-5和Anti-Ro-52抗体的存在.
- 患者死于 H1N1 肺炎继发的呼吸衰竭,并叠加了与皮肤肌炎相关的肺损伤.
结论:
- 与抗MDA-5和抗Ro-52相关的皮肤肌炎可以导致严重的,快速进展的间歇性肺病和致命的结果.
- 在患有潜在自身免疫性肺部疾病的患者中,H1N1流感感染可以起到触发因素或复杂因素的作用.
- 血清抗MDA-5抗体是识别高风险皮肤肌炎患者的关键生物标志物,而Anti-Ro-52阳性值得对间歇性肺病进行调查.
相关概念视频
01:30Pneumonia I: Introduction
213
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
213
01:25Immunodeficiency Diseases
916
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
There are three main causes of immunodeficiency...
916
01:30Pneumonia III: Complications and Assessment
182
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
182
01:21Acute Respiratory Failure-II
179
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
179
01:29Pneumonia II: Pathophysiology
229
The pathophysiology of pneumonia involves the following steps:
229
01:28Pneumonia IV: Management
305
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
305